Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 39, Issue 1, Pages 103-121Publisher
SPRINGER
DOI: 10.1007/s40618-015-0349-9
Keywords
Adjuvant treatment; Adrenocortical carcinoma; Mitotane; Overall survival; Prognostic factors; Recurrence-free survival